Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Nasdaq  >  Depomed Inc    DEPO

DEPOMED INC

(DEPO)
  Report  
SummaryChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
Business Summary
Assertio Therapeutics, Inc. is a specialty pharmaceutical company. The Company focuses on pain and other central nervous system (CNS) conditions. Its products include NUCYNTA ER (tapentadol extended release tablets), NUCYNTA IR (NUCYNTA) (tapentadol), Gralise (gabapentin), Cambia (diclofenac potassium for oral solution), Xartemis XR and Zipsor (diclofenac potassium). Its NUCYNTA ER (tapentadol extended release tablets) is a product for the management of pain severe enough to require daily long term opioid treatment, including neuropathic pain associated with diabetic peripheral neuropathy (DPN) in adults, and its NUCYNTA (tapentadol) is a product for the management of moderate to severe acute pain in adults. Its Gralise (gabapentin) is a once-daily product for the management of postherpetic neuralgia (PHN). Its Cambia (diclofenac potassium for oral solution) is a product for the acute treatment of migraine attacks.
Managers
NameAgeSinceTitle
Arthur Joseph Higgins632017President, Chief Executive Officer & Director
James P. Fogarty, MBA512016Chairman
Sean P. McKercher, MBA-2017Senior Vice President-Operations & Business
Dan A. Peisert CFA, CPA--Chief Financial Officer & Senior Vice President
Gerd G. Kochendoerfer, PhD512008Senior Vice President-Technical Operations
Stan Bukofzer, MD622018Senior VP, Chief Medical & Scientific Officer
Peter D. Staple662003Independent Director
Karen A. Dawes, MBA672008Independent Director
Louis J. Lavigne Jr., MBA712013Independent Director
James L. Tyree, MBA662016Independent Director
Equities
Vote QuantityFloatCompany-owned sharesTotal Float
Stock A 1 64,277,325 63,666,660 99.0% 0 0.0% 99.0%
Shareholders
NameEquities%
BlackRock Fund Advisors 9,887,892 15.5%
The Vanguard Group, Inc. 6,070,698 9.49%
Senvest Management LLC 5,006,637 7.83%
Renaissance Technologies LLC 4,355,738 6.81%
Dimensional Fund Advisors LP 3,741,989 5.85%
Connor, Clark & Lunn Investment Management Ltd. 3,060,189 4.79%
Armistice Capital LLC 3,000,000 4.69%
SSgA Funds Management, Inc. 2,268,338 3.55%
T. Rowe Price Associates, Inc. 1,225,965 1.92%
Acadian Asset Management LLC 1,062,060 1.66%
Company contact information
Assertio Therapeutics, Inc.
100 South Saunders Road
Suite 300
Lake Forest, IL 60045

Phone : +1.224.419.7106
Fax : +1.510.744.8001
Web : http://www.assertiotx.com
Connections : Depomed Inc
Puppet, Inc.
Babson Global, Inc.
Children's Hospital Oakland Research Institute
UCSF Benioff Children's Hospital Oakland
Seaside Therapeutics, Inc.
Zimmer US, Inc.
Lavrite LLC
Rodan & Fields LLC
The Chicago Council on Global Affairs
Children's Hospital & Research Center Foundation
Medicines 360
Symbiomix Therapeutics LLC
Ucsf Benioff Childrens Hospitals Foundation
Children's Liver Disease Foundation
Spring Development Group LLC
Nuvelution Pharma, Inc.
Genelux Corp.
Babson College
SonarMed, Inc.
Knowledgeable Decisions LLC
Tyree & D'Angelo Partners LLC
Puppet Labs, Inc.